Genomenon Press Releases
Empowering Personalized Medicine by Simplifying Genomic Interpretation
May 30, 2023 – Genomenon Wins Best of Show Award at Bio-IT World 2023 Conference and Expo
Genomenon Inc., a genomic intelligence company, today announced that it was awarded Best of Show at Bio-IT World Conference and Expo 2023 for its independent genetic disease assessment, which starts with calculating rare disease prevalence. Each year, the Best of Show Awards program at Bio-IT World recognizes innovative product solutions to important problems facing the Life Sciences industry. Genomenon’s offering was one of 33 new products considered for this prestigious award at last week’s 22nd annual event in Boston, MA. Continue Reading….
May 8, 2023 – Genomenon Recognized by Frost & Sullivan for Genomic Intelligence Solutions and Software for Pharma and Clinical Diagnostics Companies
Frost & Sullivan today announced that it has awarded Genomenon with the 2023 Global Technology Innovation Leadership Award. Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables. Continue Reading….
February 21, 2023 – Genomenon Appoints Vice President of Engineering to Leadership Team
Genomenon, an AI-driven genomics company, announced today that John Battles has been appointed Vice President of Engineering. Battles will be responsible for leading the technical vision and implementation to deliver leading edge precision medicine solutions. Continue Reading….
February 7, 2023 – Flagship Biosciences and Genomenon Partner to Advance Precision Medicine Development
Flagship Biosciences, a leader in spatial biology and biomarker analytics services, today announced a strategic partnership with Genomenon, Inc.,that aims to transform the drug development paradigm with accelerated biomarker discovery and companion diagnostics development solutions. Continue Reading….
January 10, 2023 – Genomenon Recognized as Top Tech Company to Watch in 2023 by Purpose Jobs
Genomenon, Inc., an AI-driven genomics company, has been named one of the Top Tech Companies to Watch in 2023 in Midwest tech by Purpose Jobs, the region’s largest startup and tech community. The list, which includes companies headquartered and hiring in cities such as Ann Arbor, Chicago, Cincinnati, Cleveland, Columbus, Detroit, and more, recognizes companies based on notable company announcements including fundraising, partnerships, hiring, product development, and expansions. Continue Reading….
January 5, 2023 – Genomenon to Participate in BIO Partnering at JPM During J.P. Morgan Week 2023
Genomenon, Inc., an AI-driven genomics company, announced today that it will participate in BIO Partnering at JPM, January 9-12, 2023 in San Francisco. Continue Reading….
December 15, 2022 – New Study Shows Comprehensive Genomic Evidence is Critical for Calculating Rare Disease Prevalence
Genomenon Inc., an AI-driven genomics company, today announced the publication of a paper in the Orphanet Journal of Rare Diseases that calculates the prevalence of ENPP1 deficiency—a disease claiming more than half of all infants within the first few months of life—to be more than triple the prior estimate. The study, conducted by the Genomenon scientific team and leading disease experts from the National Institutes of Health (NIH) and Münster University Children’s Hospital, highlights a core strength of Genomenon’s rigorous methodology for identifying and classifying genetic data needed to improve rare disease prevalence calculations. Continue Reading….
November 29, 2022 – Genomenon Partners with Three Rare Disease Foundations to Advance Precision Drug Development
Genomenon Inc., an AI-driven genomics company, announced a partnership with COMBINEDBrain, SynGAP Research Fund, and SLC-6A1 Connect. Genomenon will collaborate with the foundations and their pharma partners, delivering comprehensive genomic data on their diseases of focus with the goal of accelerating the development of precision drugs to treat rare neurodevelopmental disorders. Continue Reading….
November 15, 2022 – Genomenon Provides Genomic Data on 450 Diseases to Advance Early Identification of Rare Disease in Newborns
Genomenon Inc., an AI-driven genomics company, announced more details on their plan to curate the genes associated with over 450 rare diseases for the purpose of newborn screening via next generation DNA sequencing. The program is the first initiative in Genomenon’s mission to curate the entire human genome and is an essential part of the BeginNGS™ newborn sequencing project led by Rady Children’s Institute for Genomic Medicine (RCIGM). Continue Reading….
October 31, 2022 – Genomenon and Inozyme Pharma Publish Most Comprehensive Locus-Specific Database of Variants and Patients for ENPP1 Deficiency
Genomenon, Inc., an AI-driven genomics company, announced the publication of a paper in Human Mutation summarizing current knowledge of clinical and genetic findings in patients with ENPP1 Deficiency. The study, completed in collaboration with Inozyme Pharma, is the largest ever gathered, and demonstrates the necessity of comprehensive genomic data for accelerating the diagnosis of rare disease. Continue Reading….
September 13, 2022 – Genomenon Appoints Vice President of Operations to Leadership Team
Genomenon Inc., an AI-driven genomics company, announced today that Dr. Sam Globus has been appointed vice president of operations. To support Genomenon’s goal to curate the entire human genome, Globus will manage the rapid growth of the company’s data science and variant curation work. Continue Reading….
September 7, 2022 – Genomenon Integrates ClinVar Data into Mastermind to Support Clinical Decision-Making
Genomenon Inc., an AI-driven genomics company, has integrated all the variants and pathogenicity interpretations from the ClinVar database into the Mastermind Genomic Search Engine. This integration combines patient variants found by genetic testing labs and submitted to ClinVar with the scientific evidence for these variants found across the entirety of medical literature, all in a single Mastermind search. Continue Reading….
August 2, 2022 – Genomenon Partners with Rady Children’s Institute for Genomic Medicine on Newborn Screening by Next Generation Sequencing
Genomenon announced a partnership with Rady Children’s Institute for Genomic Medicine (RCIGM) that will help clinicians make better diagnosis and treatment decisions. Genomenon will fully curate all genes included in RCIGM’s recently announced BeginNGS™ (pronounced “beginnings”) newborn screening panel and deliver comprehensive data on disease-causing variants within these genes. The goal of BeginNGS is to improve infant patient outcomes by providing clinicians with powerful insight on both how these diseases form and how to treat them. Continue Reading….
June 7, 2022 – Genomenon and Agilent Partner to Improve Genomic Variant Interpretation
Genomenon, Inc., has announced a partnership with Agilent to integrate the Genomenon Mastermind Genomic Search Engine into the new version of Agilent Alissa Interpret. In the first implementation phase, users of the Alissa Interpret genomic data analysis and variant interpretation software will be able to filter and review variants with respect to the number of published articles in which variants are described and link out to view the related evidence in Mastermind. Continue Reading….
May 12, 2022 – Genomenon Wins Best of Show at Bio-IT World Conference & Expo 2022
Genomenon, Inc., an AI-driven genomics company, today announced that Bio-IT World has awarded them Best of Show for Disease-Specific Curated Content, now in the Mastermind Genomic Search Engine. Genomenon’s offering was one of 27 products considered for this prestigious award at last week’s Bio-IT World Conference & Expo in Boston. Continue Reading….
March 10, 2022 – Genomenon Raises $20M Series B Financing, Launching a New Era in AI-Powered Genomic Data
Genomenon, Inc., an AI-driven genomics company, today announced the completion of a $20 million Series B financing round. The funds will expand the company’s commercial operations and the development of its genomic data hub, which serves genetic testing labs, hospitals, pharmaceutical and biopharma companies. Genomenon leverages AI (Artificial Intelligence) to organize the world’s genomic knowledge and put it at the fingertips of doctors and clinicians to diagnose patients with rare and genetic disease and cancer, and researchers to help create precision medicine targeted at molecular drivers of disease. Continue Reading….
February 22, 2022 – Genomenon Partners with Don’t Forget Morgan to Provide New Hope for Rare Disease
Genomenon, Inc., recently announced a partnership with Don’t Forget Morgan, a nonprofit support organization focused on rare disease patients living with Beta-Propeller Protein-Associated Neurodegeneration (BPAN), a progressive disease causing abnormal iron deposits in the brain leading to profound developmental delays The goal of this collaboration is to provide resources to assist researchers and encourage pharmaceutical companies to invest in finding effective treatments for BPAN, as well as empower patient care teams with actionable genetic information. Continue Reading….
February 15, 2022 – Genomenon Awarded NIH Grant to Curate the Human Genome
Genomenon, Inc., an AI-driven genomics company, today announced that it was awarded a $1.7 million grant by the National Institutes of Health (NIH) through the Small Business Innovation Research (SBIR) program. The grant is to accelerate development of the Mastermind® Genomic Search Engine, the company’s AI-driven variant interpretation engine, with a vision of curating the entire human genome. Continue Reading….
January 20, 2022 – Genomenon Appoints New Chief Financial Officer to Leadership Team
Following a year of 125% revenue growth, Genomenon, an AI-driven genomics company, today announced that Sean Kearney has been appointed Chief Financial Officer (CFO), effective immediately. As a valuable member of Genomenon’s executive leadership team, Mr. Kearney will lead the company’s financial operations. Continue Reading….
January 4, 2022 – Genomenon and OmniTier Partner to Bring Mastermind’s Evidence Sources to CompStor Insight
Genomenon, an AI-driven genomics company, announced a partnership with OmniTier, which includes integration of the Mastermind® Genomic Search Engine into their on-premises based CompStor Insight® genomics analysis platform. This integration will allow CompStor users to preview the number of published articles related to their search and easily link out to view the evidence in Mastermind. Continue Reading….
November 30, 2021 – Genomenon Extends Insight into Genomic Evidence with Mastermind Search Companion
Genomenon, an AI-driven genomics company, today announced the new Mastermind Search Companion, a Google Chrome browser plug-in for use with 14 variant databases, Google, and Google Scholar. The free extension, available through the Chrome Web Store to all Google Chrome users enables deeper insight into genetic evidence related to searches across a wide range of variant databases used by geneticists, genetic counselors, variant scientists, and researchers. Continue Reading….
November 11, 2021 – Genomenon and Inozyme Pharma Announce Partnership to Advance Genetic Diagnosis for Rare Disease Patients
Genomenon, an AI-driven genomics company, announced a partnership with Inozyme Pharma to make critical information readily accessible to genetic testing labs and clinicians. This information will help inform diagnosis and thus treatment decisions in patients with ENPP1 Deficiency, a rare disease also known as generalized arterial calcification of infancy (GACI) or autosomal recessive hypophosphatemic rickets Type 2 (ARHR2). Continue Reading….
November 4, 2021 – Genomenon and Deep 6 AI Sign Proof of Concept Agreement to Increase Clinical Trial Matching Capabilities
Genomenon, an AI-driven genomics company, today announced a Proof of Concept Agreement with Deep 6 AI, the leader in artificial intelligence (AI)-based clinical trial acceleration software (CTAS). The collaboration offers significant value to disease researchers, clinical operations, and precision matched recruitment, accelerating the identification and treatment of diseases such as cancer, Parkinson, and Wilson disease. Continue Reading….
September 20, 2021 – Genomenon Announces Collaboration to Accelerate Genetic Diagnosis for Rare Disease Patients
Genomenon, an AI-driven genomics company, today announced a collaboration with Alexion, AstraZeneca Rare Disease that will make critical information needed for the diagnosis and treatment for a set of rare diseases more readily accessible. The goal of this collaboration is to empower genetic testing labs with the data they need to diagnose patients suffering from rare diseases. Continue Reading….
August 26, 2021 – Genomenon Hosts Clinical Genomics Experts at European Human Genetics Conference
Genomenon, the AI-driven genomics company, recently announced that it will feature expert clinicians from Acibadem Labgen in Turkey and Héritas in Argentina at this year’s European Society of Human Genetics Virtual Conference. The on-demand talk will highlight the innovative Mastermind Genomic Search Engine, and how it has made a difference in real-life clinical cases. Continue Reading….
June 1, 2021 – Genomenon and Nostos Genomics Partner to Accelerate Rare Genetic Disease Diagnoses
Genomenon announced a partnership with Nostos Genomics, which includes integration of the Mastermind® Genomic Search Engine into their cloud-based AION variant interpretation platform. This integration will allow users of AION to preview the number of published articles related to their search and easily link out to view the evidence in Mastermind. Continue Reading….
May 25, 2021 – Genomenon Welcomes New Director of Customer Success
Genomenon, a leading AI-driven genomics company, recently appointed Dr. Brittnee Jones to their leadership team as the Director of Customer Success. In this role, Brittnee will lead the company’s customer success strategy for Genomenon’s genetic testing lab and pharmaceutical customer base. Continue Reading….
May 20, 2021 – Genomenon Publishes Key Findings from the Genomic Landscape for ALS
Genomenon, an AI-driven genomics company, announced that it has published a new pharma report: Key Findings from the Genomic Landscape for ALS. Also known as Lou Gehrig’s disease, ALS is a rare neurodegenerative disorder that affects about five in 100,000 individuals and causes devastating motor, cognitive, and behavioral impairment. Furthermore, clinicians and researchers are faced with a frustrating shortage of actionable information, which results in limited genetic testing and few successful drug programs. Continue Reading….
April 12, 2021 – Genomenon and Limbus Partner to Advance Genomic Variant Interpretation
Genomenon announced a partnership with Limbus Medical Technologies, which includes integration of the Mastermind® Genomic Search Engine into the cloud-based varvis® platform. In the initial integration available now, users of varvis can preview the number of published articles related to their search and easily link out to view the evidence in Mastermind. A deeper integration using Mastermind’s advanced API is underway, which will allow users to view the relevant evidence right inside the varvis platform. Continue Reading….
March 16, 2021 – Genomenon Completes $5.3M Financing Round
Genomenon announced that it has completed a $5.3M financing round in the company. The financing will enable the company to expand its commercial operations, which serve genetic testing labs, hospitals, pharmaceutical and biopharma companies. Genomenon leverages AI (Artificial Intelligence) to organize the world’s genomic knowledge and put it at the fingertips of doctors and clinicians to diagnose patients suffering from rare & genetic disease and cancer, and researchers to help create precision medicine targeted at molecular drivers of disease. Continue Reading….
January 26, 2021 – Genomenon Announces Publication of Scientific Paper in Frontiers in Genetics
Genomenon, an AI-driven genomics company that connects the world’s genomic knowledge with patient DNA, announced that a seminal paper written by its team of scientists has been published in the Computational Genomics section of Frontiers in Genetics. Frontiers in Genetics is an open-access journal that publishes rigorously peer-reviewed research on genes and genomes relating to all domains of life. Continue Reading….
December 8, 2020 – Genomenon Recognized as Top Precision Medicine Solution Provider
Genomenon Inc., a leading genomic health IT company, today announced that Healthcare Tech Outlook has recognized Genomenon as a Top 10 Precision Medicine Solution Provider for 2020. The honor is due to its innovations in genomic intelligence for both pharmaceutical research and clinical diagnostics. Continue Reading….
November 17, 2020 – DNASTAR Integrates Genomenon Mastermind Database for Human Variant Analysis
DNASTAR® announced today the integration of the Mastermind database from Genomenon into the Lasergene Genomics software with the release of Lasergene® 17.2. With this integration, Lasergene users can now search and cross-reference NGS variant data from millions of PubMed publications. This searching and filtering capability is complemented by DNASTAR’s robust visualization and analysis tools for resequencing and human variant detection. Continue Reading….
October 13, 2020 – Genomenon Releases Copy Number Variation (CNV) Search to Enhance Genomic Interpretation
Genomenon announced today that the latest release of the Mastermind Genomic Search Engine includes Copy Number Variation (CNV) search. Since 5-30% of genetic disease is caused by deletion or duplication of genomic material, this new functionality will further accelerate diagnosis and interpretation of results for patients with genetic disease. Continue Reading….
October 7, 2020 – Genomenon and Rady Children’s Institute for Genomic Medicine Collaborate to Accelerate Diagnosis of Rare Genetic Disorders in Newborns
The Rady Children’s Institute for Genomic Medicine (RCIGM) and Genomenon, Inc. today announced a strategic collaboration to accelerate the diagnosis of critically-ill newborns with rare genetic disorders. The collaboration combines the Institute’s genomic research expertise with Genomenon’s Mastermind Genomic Search Engine to advance precision medicine for infants in an intensive care setting. Continue Reading….
August 11, 2020 – Genomenon’s Klein Named in “Top 25 Biotechnology CEOs of 2020” by TechCEOs
Genomenon announced today that CEO Mike Klein has been named to TechCEOs list of “Top 25 Biotechnology CEOs of 2020”. Klein was recognized for leading Genomenon, one of the most innovative health IT companies in genomics. Continue Reading….
June 10, 2020 – Genomenon Releases Novel Solution for Accelerated Genomic Diagnosis
Genomenon’s latest release of the Mastermind Genomic Search Engine includes enhanced search for intronic and non-coding variants across the medical literature. Mastermind users now receive more specific results when searching the comprehensive database of genomic evidence. Continue Reading….
May 12, 2020 – Genomenon Partners with enGenome to Improve Variant Interpretation Accuracy and Speed
Genomenon announced a partnership with enGenome, which includes integration of the Mastermind Genomic Search Engine into the eVai Variant Interpretation platform. eVai users can now preview the number of published articles related to their search and easily link out to view the evidence in Mastermind. Continue Reading….
April 28, 2020 – Genomenon’s Mastermind Now Finds Therapies Associated with Genetic Drivers
Genomenon announced today that the latest release of the Mastermind Genomic Search Engine includes the ability to search by therapy. Mastermind users can now query the comprehensive database of genomic evidence for over 180,000 drugs, therapies, and other interventions. Continue Reading….
March 23, 2020 – Genomenon and University of California Santa Cruz (UCSC) Genome Browser Integration Accelerates Genomic Variant Interpretation
Genomenon announced today that the University of California Santa Cruz (UCSC) Genome Browser, an open-sourced genetic knowledge base, has integrated links to Genomenon’s Mastermind Genomic Search Engine into its platform to accelerate variant curation for genomic analysis. Continue Reading….
February 26, 2020 – Genomenon Releases Genomic Landscape for Ectodermal Dysplasias for Rare Disease Week
Genomenon, home of the Mastermind Genomic Search Engine, is celebrating Rare Disease Week 2020 by making the comprehensive genomic landscape of Ectodermal Dysplasias (ED) freely available to clinical and pharma researchers. The release of this data set will provide genetic insight for doctors and researchers searching for efficacious treatments for ED, a collection of more than 100 different disorders that affect the teeth, skin, sweat glands, hair, nails, and other ectodermal structures. Continue Reading….
February 11, 2020 – Genomenon Awarded Global Company of the Year in Clinical Genomics Interpretation by Frost & Sullivan
Genomenon is commended by Frost & Sullivan for advancing Clinical Genomics Interpretation and Personalized Medicine with Its Mastermind Platform. The company’s content-rich genomic database platform and AI-driven processing help mitigate early-stage genomic translational research challenges. Continue Reading….
January 20, 2020 – Genomenon’s Mastermind Continues to Outpace Qiagen’s HGMD Genetic Database
Genomenon® announced that over 175,000 recently documented genetic variants (DNA mutations) have been added to the Mastermind® Genomic Search Engine in the 4th quarter of 2019, for a cumulative total of more than 5.9 million genetic variants. Continue Reading….
January 7, 2020 – Genomenon CEO to Present at 2020 Digital Medicine & Medtech Showcase
Genomenon®, home of the Mastermind® Genomic Search Engine, announced its participation at the 2020 Digital Health & Medtech Showcase being held in San Francisco, California January 13th – 15th, 2020 in parallel with the Biotech Showcase™ 2020 and the 38th annual J.P. Morgan Healthcare Conference. Continue Reading….
November 6, 2019 – Genomenon Accelerates Rare and Genetic Disease Research with Mastermind Version 2.0
Genomenon® announced the release of Mastermind® version 2.0 today. The Genomic Search Engine now includes the ability to search the entirety of the genomic literature by phenotypes (symptoms). This new functionality will further accelerate diagnosis of patients with genetic and rare diseases. Continue Reading….
October 15, 2019 – Genomenon’s Mastermind to be Integrated into SOPHiA Platform and Alamut Suite
Genomenon® announced today a partnership with SOPHiA GENETICS that includes incorporating the Mastermind® Genomic Search Engine into the SOPHiA Platform and the Alamut Suite. With the addition of Mastermind, users of both technologies will be able to quickly access the genomic evidence associated with human variants, shortening the search time required to interpret a variant and assess its pathogenicity. Continue Reading….
October 2, 2019 – Congenica Partners with Genomenon to Integrate Mastermind into Congenica Clinical Platform
Genomenon® announced a partnership with Congenica Ltd today that incorporates Mastermind® Genomic Search Engine results into Congenica’s industry-leading clinical decision support platform for genomic data interpretation. The goal of the partnership is to put the most up-to-date genomic research at the fingertips of geneticists diagnosing genetic diseases. Continue Reading….
October 2, 2019 – Congenica Integrates Powerful New Curated Data
Congenica Ltd, a digital health technology company enabling accelerated interpretation of complex genomic data to improve disease diagnosis, has announced significant developments to its software solution, with the integration of powerful new reference data sources, DECIPHER and Mastermind® into its clinical decision support platform. Continue Reading….
September 17, 2019 – Genomenon Partners with BPAN Warriors to Find a Cure for Ultra-Rare Disease
Genomenon®, today announced a partnership with rare disease advocacy group BPAN Warriors, with the goal of providing resources to assist researchers and encourage pharmaceutical companies to invest in finding efficacious treatments for Beta-Propeller Protein-Associated Neurodegeneration (BPAN), a progressive disease causing abnormal iron deposits in the brain. Continue Reading….
August 20, 2019 – Genomenon, Shanghai Shanyi Announce Strategic Partnership to Bring Leading Genomic Search Engine to the China Market
Genomenon® and Shanghai Shanyi Biological Technology Co., Ltd have formed a partnership to provide Genomenon’s leading Mastermind Genomic Search Engine to clinical laboratory customers in China. Genomenon’s Mastermind is the leading genomic search engine on the market. With nearly 3,500 users in over 100 countries, Mastermind has become the search engine of choice when researching patient variants for clinical NGS interpretation. Continue Reading….
August 6, 2019 – Genomenon Wins NIH Grant to Develop Micropublications for Genomic Interpretation
Genomenon®, the leading genomic search engine company, announced today that it was awarded a grant by the National Institutes of Health. The Small Business Innovation Research (SBIR) grant, awarded by the National Human Genome Research Institute*, will fund Genomenon’s further innovation in automating aspects of genomic interpretation from the research literature, and the creation of a platform for producing and sharing “micropublications” across the genomics community. Continue Reading….
July 9, 2019 – Genomenon Granted Patent on Genomic Search Engine
Genomenon® has been issued a patent from the United States Patent and Trademark Office for “Systems and Methods for Electronically Mining Genomic Data”. The patent covers the technology used to mine disease, gene, and genetic mutation and the relationships between diseases and mutations from the scientific literature. Continue Reading….
June 10, 2019 – Fusion Genes Found to be an Emerging Target in Cancer Diagnostics and Drug Development
Genomenon® has released a research report detailing fusion genes of clinical significance. Fusion genes have long been known to play an important role in the development of cancer. Identifying and documenting each newly discovered fusion is crucial in both patient diagnosis and the development of precision medicines (specifically, targeted therapeutics). The report was compiled using research data found in the Mastermind Genomic Search Engine. Continue Reading….
May 14, 2019 – Genomenon Kicks off Genomics Educators Program with Keck Graduate Institute
Genomenon® announced today that Keck Graduate Institute (KGI) has become the first academic partner in their new Genomics Educator Program. Genomenon is the creator of the Mastermind Genomic Search Engine, which provides insight into the published genomic research for every disease, gene, and variant found in the scientific literature. Continue Reading….
April 24, 2019 – EY Announces Mike Klein of Genomenon Entrepreneur Of The Year 2019 Award Finalist
Widely considered one of the most prestigious business awards programs in the U.S., the program recognizes entrepreneurs and leaders of high-growth companies who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities, while also transforming our world. Klein was selected as a finalist by a panel of independent judges. Continue Reading….
April 22, 2019 – Genomenon Wins Best of Show at Bio-IT 2019
Genomenon®, the leading genomic search company, today announced that Bio-IT World has awarded them Best of Show for the Mastermind Genomic Search Engine. During the April 18th awards ceremony, Mastermind was applauded as a product that was unique, important to the industry, and offered a compelling return on investment. Continue Reading….
April 16, 2019 – Genomenon Partners with Google to Make Genomic Data Available on Google Cloud Platform
Genomenon® announced a partnership with Google to make the company’s genomic mutation data available on Google Cloud Platform. Genomenon’s Cited Variants Reference (CVR) data will be a public dataset available in BigQuery, Google Cloud’s big data and machine learning data warehouse, for use in genomic applications. Continue Reading….
April 2, 2019 – LifeMap Sciences and Genomenon Partner to Integrate Mastermind Genomic Search Engine into GeneCards Suite and TGex
LifeMap Sciences, the leading integrated biomedical knowledgebase company and a leading provider of tertiary NGS analysis and interpretation solutions for genetic disorders, and Genomenon®, the leading genomic search company, announced today that they have entered into a partnership to improve LifeMap’s GeneCards knowledgebase and provide accelerated interpretation of genetic disorders by integrating the Mastermind Genomic Search Engine. Continue Reading….
March 18, 2019 – Genomenon Honored as One of the 2019 “Michigan 50 Companies to Watch”
Genomenon® has been recognized as one of the 2019 “Michigan 50 Companies to Watch,” an awards program presented by Michigan Celebrates Small Business. Selected companies like Genomenon are known for their exceptional entrepreneurial leadership, creation of innovation or use of innovation in creative ways, and their sustainable competitive advantage. Continue Reading….
February 28, 2019 – Rare Genomics Institute Demonstrates the Power of Genomenon’s AI-Based Technology in Diagnosis
Rare Genomics Institute, a nonprofit providing direct support to undiagnosed rare disease patients, announced on Rare Disease Day that they were able to diagnose a previously undiagnosed patient with the use of the Mastermind Genomic Search Engine®, a clinical decision support tool by Genomenon®. Continue Reading….
February 19, 2019 – Genomenon and Diploid Sign Partnership Agreement to Accelerate Rare Disease Diagnostics
Genomenon® and Diploid announced today that the Mastermind® Genomic Search Engine has been integrated Into Diploid’s Moon diagnostic software, an advancement that will improve genome interpretation for rare disease diagnostics. Continue Reading….
February 4, 2019 – David Anstey Joins Genomenon as Vice President of Sales and Business Development
Genomenon® announced today that industry veteran David Anstey has joined the executive team as the company’s Vice President of Sales. In his new role, Anstey is responsible for building out and leading the company’s sales and business development efforts. Continue Reading….
January 17, 2019 – Emergence of Cancer Drug Resistance and Focus on Rare Diseases Found in 2018 Published Research
Genomenon® has released a research report detailing the top emerging genomic variants in 2018. This year’s data showed a continued trend of studies and new discoveries detailing variants that are becoming increasingly resistant to drugs. The report was compiled using the research data found in the Mastermind® Genomic Search Engine. Continue Reading….
January 8, 2019 – Genomenon Completes $2.5 Million Financing Round
Genomenon® announced that it has completed a $2.5M equity financing round. Investors in this round include IrishAngels, H. W. Kaufman Group, and all of Genomenon’s earlier investors including the company’s CEO, Mike Klein. The company initially set out to raise $2.0M in new financing, but with strong interest from both current and new investors, the round was oversubscribed. Continue Reading….
November 27, 2018 – Genomenon Publishes 3.7 Million Genomic Variants to Speed DNA Interpretation
® announced that it has published the first Cited Variant Reference (CVR), a comprehensive catalogue of genetic variants cited in the medical literature. The term “variant” refers to a genomic mutation in the DNA – key data used in searching for causes of cancer and rare diseases. Continue Reading….
October 29, 2018 – GenomOncology and Genomenon Partner to bring Genomic Literature Search to Molecular Tumor Board
GenomOnocology and Genomenon® announced today a partnership that incorporates Mastermind® Genomic Search Engine results into GenomOncology’s Molecular Tumor Board. The goal of the partnership is to put the most up-to-date genomic research at the fingertips of oncologists making treatment decisions for critically ill cancer patients. Continue Reading….
October 18, 2018 – Fabric Genomics and Genomenon Sign Partnership Agreement to Speed Genomic Interpretation
Fabric Genomics™, a global leader in clinical interpretation of genomic data, and Genomenon®, the leading genomic data search company, announced today that they have entered into a partnership with the goal of further strengthening clinical genomic interpretation and variant classification. Continue Reading….
October 16, 2018 – Genomenon Partners with Rare Genomics Institute, Begins with Philanthropic Donation
Genomenon® announced today that they will donate Mastermind® Genomic Search Engine licenses to the entire team of clinical scientists at Rare Genomics Institute to accelerate their work for patients with rare diseases. Continue Reading….
September 24, 2018 – Genomenon, Inc. Named TiE20 Award Winner at TiECon Detroit 2018
Genomenon® has been selected as a 2018 TiE20 Winner for the prestigious TiE20 Awards Program. The company has been recognized for its work in Next Generation Sequencing (NGS) interpretation with the Mastermind® Genomic Search Engine. Mastermind assists doctors and researchers in connecting patient DNA with the most relevant medical research. The competition is a part of TiECon Detroit 2018, Michigan’s largest conference for entrepreneurs. Continue Reading….
September 18, 2018 – Genomenon Advances its Genomic Search Engine for Pharma and Diagnostic Labs with Supplemental Data
Mastermind® Genomic Search Engine indexes 500,000 new genomic variants from supplemental data found in scientific publications. Researchers and clinicians can now use the Mastermind Genomic Search Engine to expand their search into the supplemental materials that are often published alongside research papers and frequently contain vast collections of genomic information. Continue Reading….
July 31, 2018 – Genomenon Awarded Phase 2 NIH Grant to Apply Artificial Intelligence to Genomic Interpretation
Genomenon®, the leading genomic data search company, today announced that it was awarded a Phase 2 Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH). Continue Reading….
June 26, 2018 – The University of Vermont Health Network Standardizes on Genomenon’s Mastermind Genomic Search Engine
Genomenon® announced today that the University of Vermont Health Network has selected Genomenon’s Mastermind® Genomic Search Engine as their standard for searching medical literature for variant interpretation within the Department of Pathology and Laboratory Medicine. Continue Reading….
June 7, 2018 – Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Services
Through the Fluidigm-Genomenon joint panel design services offering, researchers will be able to accelerate the design of disease-specific next-generation sequencing (NGS), genotyping, and real-time PCR panels for use with highly efficient Fluidigm® automated microfluidic systems. Continue Reading….
May 23, 2018 – Swift Biosciences and Genomenon Announce Partnership to Accelerate Biomarker Selection for Targeted NGS Panels
Two Ann Arbor biotech companies provide translational researchers a faster, more comprehensive way to design Accel-Amplicon panels for variant discovery and screening studies Continue Reading….
April 24, 2018 – Genomenon’s Machine Learning Algorithm Identifies Key Biomarkers for Rare Genetic Disorders of Obesity
Genomenon®, the leading genomic data search company, today announced a partnership with Rhythm Pharmaceuticals, a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity, to create a database of genetic mutations associated with obesity as documented in the medical literature. Continue Reading….
April 9, 2018 – Genomenon Adds ACMG Classification Features to the Mastermind Genomic Search Engine
Genomenon® announced support for ACMG variant classification within the Mastermind® Genomic Search Engine. Mastermind users can accelerate their genomic interpretation by searching the scientific literature that fits each individual ACMG classification criteria.. Continue Reading….
April 2, 2018 – Genomenon Partners with Veritas Genetics to Create Next Generation Genomic Literature Prioritization Engine Powered By Machine Learning and AI
Companies Collaborate to Aggressively Reduce the Time and Cost of Variant Interpretation to Further Scale Global Adoption of Whole Genome Sequencing Continue Reading….
February 20, 2018 – GenomeNext Embeds Mastermind Genomic Search Results in Olympus Platform
GenomeNext and Genomenon® Partner to Speed Variant Curation for Whole Exome and Whole Genome Analysis. Continue Reading….
February 6, 2018 – Genomenon and Saphetor Announce Data Sharing Partnership
The Mastermind now provides a link to VarSome for gene and variant information from 30 different genomic databases. VarSome includes a link to Mastermind search results for the scientific literature related to each variant and gene in VarSome. Continue Reading….
November 14, 2017 – Genomenon Announces First Automated, Evidence Based Blood Cancer Panel
Genomenon® Presents Details of a Pan-Hematopoietic Malignancy Gene Panel with Supporting Evidence. Continue Reading….
October 18th, 2017 – LifeOmic Leverages Genomenon’s Mastermind Genomic Search Engine for Variant Interpretation
LifeOmic Partners with Genomenon® to Streamline Genomic Interpretation of Whole Genomes Continue Reading….
October 16th, 2017 – Genomenon Announces Free Edition of Mastermind Genomic Search Engine
Genomenon® is offering a Free Edition of the Mastermind® Genomic Search Engine to clinical, research and academic institutions to advance genomic analysis. Continue Reading….
August 8, 2017 – Genomenon Announces the Next Advance in Genomic Interpretation
Mastermind® v1.3 Genomic Search Engine Delivers Faster, Streamlined Genomic Interpretation. Continue Reading….
April 25, 2017 – Genomenon Wins $1.8M NIH Grant to Automatically Curate Genomic Literature
Fast track SBIR grant will accelerate publication-driven genomic analysis. Continue Reading….
March 21, 2017 – Genomenon Delivers Evidence-Based Gene Panel Design
Rational Panel Design Service Delivers Candidate Biomarkers Culled from Medical Literature. Continue Reading….
February 13, 2017 – Genomenon Launches Mastermind Genomic Search Engine for Faster Genomic Curation
New Product Dramatically Accelerates Genetic Variant Curation – Speeding Time to Patient Diagnosis. Continue Reading….
November 10, 2016 – Genomenon Completes $1.8 Million Extended Seed Financing Round
Genomenon®, a DNA interpretation software company, today announced the completion of a $1.8M investment. Continue Reading….
October 19, 2016 – Genomenon Hires New CEO, Prepares to Launch First Product
Genomenon’s Board of Directors recently appointed Mike Klein to the position of Chief Executive Officer as the company prepares to launch its first product, Mastermind®, the worlds first genomic search engine. Continue Reading….
MASTERMIND GENOMIC SEARCH ENGINE
The Cure for Curation
The Cure for Curation